THREAD, which develops technology and offers consulting services for decentralized clinical trials, announced a new collaboration this week with Amazon Web Services.

WHY IT MATTERS
AWS will help develop new enhancements for the THREAD platform, bringing scalable automation and built-in AI to enabling faster and more efficient trials by enabling higher quality data capture across the lifecycle of a clinical study.

In addition to improving access for research participants, the companies say they hope the collaboration will speed up the ability to offer and initiate co-created and configured trials by reducing the start-up time to onboard customers by up to 30%.

Another goal is to enable customers to reduce inefficiencies by 30% and achieve up to 25% cost savings when pre-completing data, significantly reducing data capture and removing source data verification.

The hope is to provide a more comprehensive view of participant data across studies with enhanced security, AI support and operational controls – also to help customers to more precisely assess studies' success by enabling real-time visibility into richer data streams, real-time grades on study performance.

THREAD is working with AWS Professional Services to design advanced machine learning architecture and AI models to automate processes for real-time data capture, auto-populating data workflows and more.

THE LARGER TREND
There's been big momentum for AI and machine learning in clinical trial management, especially since the pandemic, in the U.S. and around the world.

This past October, Cerner launched Enviza, a new operating unit focused on innovating new approaches to automated data management and expanding participation in clinical trials.

That same month, we offered an inside look at how Intel and ConsenSys Health are combining blockchain and AI for clinical trials management.

ON THE RECORD
"The breadth and depth of AWS's machine learning and cloud capabilities will help support THREAD teams as they work to automate processes, reduce inefficiencies, and monitor and support clinical trials," said Dan Sheeran, general manager, healthcare and life sciences at Amazon Web Services, in a statement.

"In collaboration with Amazon Web Services, we are further scaling our DCT platform with next-level automation, AI/ML offerings, and optimized features focused to meet the evolving needs of our customers, research sites, and participants," added THREAD CEO John Reites.

Twitter: @MikeMiliardHITN
Email the writer: mike.miliard@himssmedia.com
Healthcare IT News is a HIMSS publication.